Brief: Knight Announces Filing Of Preliminary Base Shelf Prospectus
Dec 10 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT ANNOUNCES FILING OF PRELIMINARY BASE SHELF
PROSPECTUS
* KNIGHT THERAPEUTICS - FILED PRELIMINARY SHORT FORM BASE
SHELF
PROSPECTUS TO OFFER FOR SALE AND ISSUE UP TO $360 MILLION OF
COMMON SHARES
* KNIGHT THERAPEUTICS - FILED PRELIM SHORT FORM BASE SHELF
PROSPECTUS TO OFFER FOR SALE, ISSUE UP TO $360 MILLION OF
SUBSCRIPTION RECEIPTS, DEBT SECURITIES
Source text for Eikon: ID:nGNXbXv0qv
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil